Immunoblot detection of antibodies to myelin basic protein in Alzheimer's disease patients

Vijendra K. Singh, Yi Yuan Yang, Edith A. Singh

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Based on a suspected pathological relationship of autoimmunity in Alzheimer's disease (AD), antibodies to myelin basic protein (MBP) were investigated in the sera of AD patients, healthy controls and disease controls. As detected by the protein-immunoblotting technique at a screening serum dilution of 1:400, sera from 16 of 18 (89%) AD patients were positive for antibodies to MBP. In contrast, sera from only 7 of 90 controls (healthy adults and elderlies, Parkinson's disease patients, mentally-retarded children and Down's syndrome patients) showed a positive reaction. This approximately 11-times higher incidence of antibodies to MBP in AD patients was statistically significant (P≤0.0001) and may indicate an autoimmune process in the pathophysiology of the disease.

Original languageEnglish
Pages (from-to)25-28
Number of pages4
JournalNeuroscience Letters
Volume147
Issue number1
DOIs
Publication statusPublished - Nov 23 1992
Externally publishedYes

Fingerprint

Myelin Basic Protein
Alzheimer Disease
Antibodies
Serum
Mentally Disabled Persons
Down Syndrome
Autoimmunity
Immunoblotting
Parkinson Disease
Incidence
Proteins

Keywords

  • Alzheimer's disease
  • Autoantibody
  • Autoimmunity
  • Myelin basic protein

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Immunoblot detection of antibodies to myelin basic protein in Alzheimer's disease patients. / Singh, Vijendra K.; Yang, Yi Yuan; Singh, Edith A.

In: Neuroscience Letters, Vol. 147, No. 1, 23.11.1992, p. 25-28.

Research output: Contribution to journalArticle

@article{9fe05b673d3e4734bd8623a828a08c8c,
title = "Immunoblot detection of antibodies to myelin basic protein in Alzheimer's disease patients",
abstract = "Based on a suspected pathological relationship of autoimmunity in Alzheimer's disease (AD), antibodies to myelin basic protein (MBP) were investigated in the sera of AD patients, healthy controls and disease controls. As detected by the protein-immunoblotting technique at a screening serum dilution of 1:400, sera from 16 of 18 (89{\%}) AD patients were positive for antibodies to MBP. In contrast, sera from only 7 of 90 controls (healthy adults and elderlies, Parkinson's disease patients, mentally-retarded children and Down's syndrome patients) showed a positive reaction. This approximately 11-times higher incidence of antibodies to MBP in AD patients was statistically significant (P≤0.0001) and may indicate an autoimmune process in the pathophysiology of the disease.",
keywords = "Alzheimer's disease, Autoantibody, Autoimmunity, Myelin basic protein",
author = "Singh, {Vijendra K.} and Yang, {Yi Yuan} and Singh, {Edith A.}",
year = "1992",
month = "11",
day = "23",
doi = "10.1016/0304-3940(92)90766-Z",
language = "English",
volume = "147",
pages = "25--28",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Immunoblot detection of antibodies to myelin basic protein in Alzheimer's disease patients

AU - Singh, Vijendra K.

AU - Yang, Yi Yuan

AU - Singh, Edith A.

PY - 1992/11/23

Y1 - 1992/11/23

N2 - Based on a suspected pathological relationship of autoimmunity in Alzheimer's disease (AD), antibodies to myelin basic protein (MBP) were investigated in the sera of AD patients, healthy controls and disease controls. As detected by the protein-immunoblotting technique at a screening serum dilution of 1:400, sera from 16 of 18 (89%) AD patients were positive for antibodies to MBP. In contrast, sera from only 7 of 90 controls (healthy adults and elderlies, Parkinson's disease patients, mentally-retarded children and Down's syndrome patients) showed a positive reaction. This approximately 11-times higher incidence of antibodies to MBP in AD patients was statistically significant (P≤0.0001) and may indicate an autoimmune process in the pathophysiology of the disease.

AB - Based on a suspected pathological relationship of autoimmunity in Alzheimer's disease (AD), antibodies to myelin basic protein (MBP) were investigated in the sera of AD patients, healthy controls and disease controls. As detected by the protein-immunoblotting technique at a screening serum dilution of 1:400, sera from 16 of 18 (89%) AD patients were positive for antibodies to MBP. In contrast, sera from only 7 of 90 controls (healthy adults and elderlies, Parkinson's disease patients, mentally-retarded children and Down's syndrome patients) showed a positive reaction. This approximately 11-times higher incidence of antibodies to MBP in AD patients was statistically significant (P≤0.0001) and may indicate an autoimmune process in the pathophysiology of the disease.

KW - Alzheimer's disease

KW - Autoantibody

KW - Autoimmunity

KW - Myelin basic protein

UR - http://www.scopus.com/inward/record.url?scp=0026496198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026496198&partnerID=8YFLogxK

U2 - 10.1016/0304-3940(92)90766-Z

DO - 10.1016/0304-3940(92)90766-Z

M3 - Article

VL - 147

SP - 25

EP - 28

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 1

ER -